3-Jun-2026 - The Globe and Mail Wells Fargo Releases a Buy Rating on Dexcom (DXCM) In a report released yesterday, Larry Biegelsen from Wells Fargo assigned a Buy rating to Dexcom, with a price target of $85.00. The company’s shares closed yesterday at $74.87. Unlock trusted, ...
21-May-2026 - Seeking Alpha DexCom Might Finally Be Cheap Enough DexCom's improved fundamentals and a 15% lower stock price present a more attractive entry. Learn why DXCM stock is a Buy.
6-May-2026 - StockStory.org 5 insightful analyst questions from DexCom’s Q1 earnings call DexCom’s first quarter saw revenue growth driven by new product launches and increased adoption, particularly among people with type 2 diabetes who are not on insulin. Management highlighted progress ...
Latest DXCM Trades by Congress Members
15-MAY-2025 - Rob Bresnahan, PA (District 8) purchased between $1,001 and $15,000.
3-Jun-2026 - The Globe and Mail Wells Fargo Releases a Buy Rating on Dexcom (DXCM) In a report released yesterday, Larry Biegelsen from Wells Fargo assigned a Buy rating to Dexcom, with a price target of $85.00. The company’s shares closed yesterday at $74.87. Unlock trusted, ...
21-May-2026 - Seeking Alpha DexCom Might Finally Be Cheap Enough DexCom's improved fundamentals and a 15% lower stock price present a more attractive entry. Learn why DXCM stock is a Buy.
6-May-2026 - StockStory.org 5 insightful analyst questions from DexCom’s Q1 earnings call DexCom’s first quarter saw revenue growth driven by new product launches and increased adoption, particularly among people with type 2 diabetes who are not on insulin. Management highlighted progress ...
